BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15633248)

  • 1. Cytotoxicity of epigallocatechin-3-gallate to LNCaP cells in the presence of Cu2+.
    Yu HN; Shen SR; Xiong YK
    J Zhejiang Univ Sci B; 2005 Feb; 6(2):125-31. PubMed ID: 15633248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
    Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR
    Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.
    Yu HN; Yin JJ; Shen SR
    J Agric Food Chem; 2004 Feb; 52(3):462-6. PubMed ID: 14759133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
    Gupta S; Ahmad N; Nieminen AL; Mukhtar H
    Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
    Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA
    Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells.
    Sadava D; Whitlock E; Kane SE
    Biochem Biophys Res Commun; 2007 Aug; 360(1):233-7. PubMed ID: 17585882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate affects the growth of LNCaP cells via membrane fluidity and distribution of cellular zinc.
    Yang JG; Yu HN; Sun SL; Zhang LC; He GQ; Das UN; Ruan H; Shen SR
    J Zhejiang Univ Sci B; 2009 Jun; 10(6):411-21. PubMed ID: 19489106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
    Hastak K; Agarwal MK; Mukhtar H; Agarwal ML
    FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LNCaP cells exposed to ceramic drug delivery treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid.
    Richards LR; Jones P; Hughes J; Benghuzzi H; Tucci M
    Biomed Sci Instrum; 2007; 43():242-7. PubMed ID: 17487088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells.
    Rao SD; Pagidas K
    Anticancer Res; 2010 Jul; 30(7):2519-23. PubMed ID: 20682977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of free Zn(2+) enhancing inhibitory effects of EGCG on the growth of PC-3 cells: interactions with mitochondria.
    Yang J; Yu H; Sun S; Zhang L; Das UN; Ruan H; He G; Shen S
    Biol Trace Elem Res; 2009 Dec; 131(3):298-310. PubMed ID: 19326061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
    Lim YC; Cha YY
    J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
    Sanna V; Pintus G; Roggio AM; Punzoni S; Posadino AM; Arca A; Marceddu S; Bandiera P; Uzzau S; Sechi M
    J Med Chem; 2011 Mar; 54(5):1321-32. PubMed ID: 21306166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Zn2+ in epigallocatechin gallate affecting the growth of PC-3 cells.
    Chen X; Yu H; Shen S; Yin J
    J Trace Elem Med Biol; 2007; 21(2):125-31. PubMed ID: 17499153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.
    Hagen RM; Chedea VS; Mintoff CP; Bowler E; Morse HR; Ladomery MR
    Int J Oncol; 2013 Jul; 43(1):194-200. PubMed ID: 23615977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
    Stuart EC; Scandlyn MJ; Rosengren RJ
    Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.